|
|
|
|
|
|
Sponsored by: |
University of California, Irvine |
Information provided by: | University of California, Irvine |
ClinicalTrials.gov Identifier: | NCT00611065 |
The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to improve differential diagnosis between prostate cancer and benign prostate hyperplasia or other benign diseases.
Condition | Intervention |
Prostate Lesions |
Device: magnetic resonance imaging |
MedlinePlus related topics: | Cancer MRI Scans Prostate Cancer |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment |
Official Title: | Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging |
Estimated Enrollment: | 60 |
Study Start Date: | June 2007 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 21 Years to 80 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Min-Ying Su, PhD | 949-824-6001 | msu@uci.edu |
United States, California | |||||
Center for Functional Onco-Imaging, University of California | Recruiting | ||||
Irvine, California, United States, 92697 | |||||
Contact: Diane Huebner 949-824-6001 dkhuebne@uci.edu |
University of California, Irvine |
Principal Investigator: | Min-Ying Su, PhD | University of California, Irvine |
Responsible Party: | University of California, Irvine ( Min-Ying Su, Associate Professor ) |
Study ID Numbers: | UCI-HS-2007-5671 |
First Received: | January 12, 2008 |
Last Updated: | July 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00611065 |
Health Authority: | United States: Institutional Review Board |
|
|